ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

Scientific Session 6: Therapeutic Interventions
12:02

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Long-term Impact of Early and Deeper Molecular Response in Newly Diagnosed CML-CP Patients Receiving Radotinib: Three Years Follow-up of Rerise Study

FEATURING Young Rok Do
  • 7 views
  • November 23, 2018
20:26

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Are TKI Really Safe?

FEATURING Carlo Gambacorti-Passerini
  • 7 views
  • November 23, 2018
11:40

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Long-term Results of a Phase 2 Trial of Nilotinib 400 Mg Twice Daily in Newly Diagnosed Patients with Chronic Phase of Chronic Myeloid Leukemia

FEATURING Lucia Masarova
  • 7 views
  • January 2, 2019